whereas the PCR remained almost unaffected. The addition of placental RNase inhibitor (5 ) to leukocyte lysate did not improve the assay.
Other published methods use a lysate directly from a small number of leukocytes or cultured cells (6 -9 ) , or from boiled cell samples (10 ) . Low numbers of cells can be used without RNA extraction if proper RNase inhibitors are added and if there is universal expression of the mRNA being studied. Heating the sample may partially destroy the mRNA, decreasing the intact transcript of the gene studied to below the detection limit. The purpose of this study was to characterize the RT-inhibitory activity of leukocyte lysate. We found that most of the inhibitory activity is contributed by the eosinophil-derived neurotoxin (EDN), a highly potent ribonuclease.
Materials and Methods determination of rt-inhibiting activity
The RT-PCR assay designed to detect the Ph 1 chromosome of chronic myelogenous leukemia patients (3 ) was used to study reverse transcription inhibitors. Briefly, a 5-L aliquot of leukocyte lysate or diluted chromatography-purified fraction was added to 15 L of a reverse transcription mixture containing a specific reverse primer, 5Ј-GACCCTGAGGCTCAAAGTC-3Ј (from exon 2 of the abl gene), 50 U of Moloney murine leukemia virus (M-MLV) reverse transcriptase (Life Technologies), 20 U of RNasin ® (Promega Corp.) and 50 -100 Ph 1 chromosomepositive K562 cells. The tubes were incubated for 30 min at 37°C. In one experiment, avian myeloblastosis virus (AMV) reverse transcriptase (Finnzymes) instead of M-MLV enzyme was used at 42°C. After incubation, the tubes were heated for 5 min at 100°C, and the PCR mixture (80 L) with the forward primer 5Ј-TGT-GAAACTCCAGACTGTCC-3Ј (from exon 2 of the bcr gene) and 1 U of AmpliTaq ® DNA polymerase (PerkinElmer Corp.) were added. The PCR conditions were as follows: 50 s at 95°C; 1 min at 55°C; and 2 min at 72°C for 30 cycles. The 170-bp amplification products were quantified by a sensitive solution hybridization assay using streptavidin-coated microtitration wells and biotin-and europium-labeled probes and by measuring the timeresolved fluorescence of liberated europium (3, 11 ) . We observed that the leukocyte lysate or its chromatographypurified fractions did not inhibit the PCR or hybridization phases of the assay (data not shown). Total RNA extractions were made with the method of Chomczynski and Sacchi (12 ) purification and identification of the rt-inhibiting factor from leukocytes Leukocyte lysate. Leukocytes were collected by centrifugation from the buffy coats of discarded whole blood bags after sedimentation of the erythrocytes with 12 g/L dextran. The composition of the leukocytes was as follows: 31.3% lymphocytes, 56.5% neutrophils, 0.9% basophils, 2.6% eosinophils, 4.0% monocytes, and 4.7% large unstained cells. We washed the cells once with phosphatebuffered saline (PBS), and 3 ϫ 10 9 leukocytes were lysed in 8 mL of 20 mmol/L Tris-HCl buffer, pH 7.4, for 5 min at room temperature. After centrifugation at 5000g for 10 min at 4°C, the pellet was washed with 6 mL of the same buffer and centrifuged again. The volume of the combined supernatants was 14 mL, and the protein concentration 29.9 g/L, as determined with the folin-phenol reagent (13 ) .
Ion-exchange chromatography. Leukocyte lysate (13.5 mL) was applied to a 5-mL HiTrap ™ SP cation-exchange column (Pharmacia Biotech), conditioned with 20 mmol/L Tris-HCl, pH 7.4. The column was washed with 70 mL of the buffer at a flow rate of 2 mL/min, and 5-mL fractions were collected. The proteins adsorbed to the column were eluted with 40 mL of the same buffer containing 2 mol/L NaCl. The ultraviolet absorption of proteins at 280 nm was recorded. The inhibition of reverse transcription was determined from fractions diluted 1:50. Fractions 15 and 16, which contained the RT-inhibiting activity, were concentrated to 1.7 mL using a Centricon ™ 30 concentrator (Amicon, Inc.). The RT-inhibiting activity was totally retained by the 30 000 molecular weight sieve. The protein concentration of the preparation was 1.25 g/L.
Gel filtration. A 1-mL aliquot of the active preparation obtained by ion-exchange chromatography was applied to a Superdex ® 200 HR 10/30 gel filtration column (Pharmacia Biotech). The column was eluted with 50 mmol/L Tris-HCl buffer containing 9 g/L NaCl, pH 7.4, at a flow rate of 0.6 mL/min, and 1-mL fractions were collected. Fractions 19 and 20, which contained the RT-inhibiting activity, were combined and concentrated to 0.6 mL using a 3000 molecular weight sieve (Centricon 3; Amicon Inc.). The protein concentration of the preparation was 0.31 g/L.
Reversed-phase chromatography. The concentrated active fraction from gel filtration (0.5 mL) was loaded onto a Vydac C 4 determination of edn from leukocyte lysates EDN [also known as eosinophil protein X (EPX)] was determined using the EPX RIA kit from Pharmacia Diagnostics. The polyclonal antiserum of the kit was raised in rabbits against purified human EPX (14 ). Lysed leukocytes were centrifuged at 12 000g for 5 min, the supernatant was diluted to contain 10 6 to 10 7 lysed cells/mL, and the EDN content of the lysate was determined with the EPX/EDN RIA.
fractionation of leukocytes by ficoll-paque ᭨ density gradient
The leukocytes from 10-mL blood samples from four healthy donors were separated from erythrocytes with 12 g/L dextran sedimentation. The leukocytes (2.5-5% eosinophils) were washed with PBS and fractionated to mononuclear cell and granulocyte fractions using Ficoll-Paque density gradient solution (Pharmacia Biotech). The mononuclear cells (1 ϫ 10 6 ) were lysed with 500 K562 cells in 50 L of water containing 80 U of RNasin, and 5 L of centrifuged lysates was used in the Ph 1 chromosome RT-PCR assay. The EDN content of similar lysates without RNasin was determined by the EPX/EDN RIA.
fractionation of leukocytes by cd16 antibodies
Monoclonal anti-CD16 (clone LNK16; HyTest Ltd.) was first biotinylated as described previously (15 ) . Streptavidin-coated microtitration strips (Wallac Co.; cat. no. C122-105) were incubated with the biotinylated anti-CD16 (30 mg/L, 70 L/well) for 1.5 h at room temperature. The wells were washed three times with PBS, and 200 000 leukocytes (separated from blood with 12 g/L dextran) were added in 50 L of PBS containing 2 g/L human serum albumin. Leukocytes were incubated for 30 min at room temperature after which unbound cells were washed out three times using the same buffer. Anti-CD16-bound cells were treated with chymopapain (ChymoCell-T; The Boots Company PLC) at 20 kat units/well for 30 min at room temperature to separate the cells from the antibody. The cells were collected, counted, and centrifuged to obtain 1 ϫ 10 6 cells per tube. The Fc gamma receptor III, CD16, is expressed on neutrophils and basophils but not on eosinophils. The eosinophil-depleted fractions were lysed in 50 L of autoclaved water, and the centrifuged cell lysates were used for the RT-PCR assay and EDN determination as described above.
Results

inhibition of reverse transcription by leukocyte lysate
The number of lysed leukocytes needed to inhibit reverse transcription by 50% was ϳ7000 when M-MLV reverse transcriptase was used and 4000 when the AMV enzyme was used (Fig. 1) . In both cases ϳ25 000 lysed leukocytes totally inhibited the reverse transcription reaction. Table 1 shows that the RNase inhibitors were unable to prevent inhibition of reverse transcription when the RT-PCR tube contained a lysate of 200 000 leukocytes. The only positive signal, which was only slightly positive, was obtained when RNase block II was present in the lysate. In addition, ribonucleoside-vanadyl complex without leukocytes showed a 78% inhibition of the assay. purification and identification of the rt-inhibiting factor from leukocytes
The three chromatographic steps in the purification of RT-inhibiting factor from leukocytes are shown in Fig. 2 . In the first ion-exchange step ( Fig. 2A) , ϳ20% of the activity was lost with the main protein fraction, which did not adsorb to the column. In the following gel filtration step, the elution volume (19 mL) of the fraction 19 with the highest RT-inhibitory activity indicates a globular protein of M r 18 000 (Fig. 2B) . The RP chromatography revealed at least 20 fractions that absorbed ultraviolet Clinical Chemistry 45, No. 4, 1999 light at 280 nm (Fig. 2C) . The highest RT-inhibitory activity was in fraction 5. The yield and purification factors in the course of chromatographic procedures are shown in Table 2 . The results are based on the determination of EDN and protein from the chromatographic fractions.
sequence analysis
The amino acid sequence of protein from fraction 4 after RP chromatography was as follows: DIPEVVVSLAWDESL, which matches the sequence for human neutrophil 56-amino acid prodefensins (M r 6306 for prodefensins 1 and 2; M r 6350 for prodefensin 3) of the SWISS-PROT Protein Sequence Databank (University of Geneva and European Bioinformatics Institute, Geneva, Switzerland). The sequence obtained from fraction 5 was (x ϭ not identified): KPPQFTxAQxFETQH, which matches the sequence for nonsecretory ribonuclease precursor, also known as EDN or EPX. The molecular weight of EDN polypeptide without the 27-amino acid secretory peptide is 15 463. Theoretical pI values of 9.2 (SWISS-PROT Databank) or 8.9 (16 ) have been calculated for the molecule. The molecular weight of mature granule protein depends on the degree of glycosylation; a molecular weight range of 18 000 -25 000 has been reported, with the major band being approximately M r 18 000 in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (17, 18 ) .
mass analysis
The mass analysis of fraction 5 after RP chromatography showed four peaks ( Fig. 3 ): one at m/z 17 444, denoting glycosylated EDN; a double peak of EDN at m/z 8823.2 and 8589.2; and a third peak at m/z 6337.9, denoting a mixture of the 56-amino acid prodefensins 1-3 (19 ) . Table 3 shows that 77.4% (range, 57-106%) of the maximum signal was recovered from a mixture of 10 5 leukocytes and 50 K562 cells in Ph 1 chromosome RT-PCR when the CD16 ϩ granulocytes were used, and 52.8% (range, 41-72%) of the signal when the mononuclear cell fraction of the Ficoll-Paque density gradient separation was used. These values are far above the 24.4% signal recovered by the standard total RNA extraction method. The EDN content of cells was approximately one-tenth of that of unfractionated leukocytes. It can be calculated that 10 5 unfractionated leukocytes (with 2500 -5000 eosinophils), the minimum amount for the analysis of residual disease using RT-PCR, contain ϳ3.6 ng of EDN.
effect of eosinophil removal
Discussion
We identified the main RT-inhibiting factor of leukocytes as EDN, using the three-step chromatographic procedure and amino acid sequencing. The binding of EDN to cation-exchange resin at neutral pH enabled a high firststep purification. During this step, ϳ20% of the activity was lost with neutral and acidic proteins. Most of this RT-inhibiting activity was probably EDN and other cellular ribonucleases (20 ) that were associated with the main protein fraction and were removed during the column wash.
The purification procedure yielded EDN with some contamination from defensins. Mass analysis showed a molecular weight of 17 444 for EDN, of which the polypeptide body accounts for 15 463. Analyses of urinary ribonuclease U s (21 ) and of kidney, liver, and spleen nonsecretory ribonucleases (22 ) have shown that this type of RNase carries a tryptophan-linked mannosyl residue EDN belongs to the ribonuclease superfamily and has high ribonuclease activity in addition to its reported neurotoxic and helminthotoxic effects (23) (24) (25) . Recently, part of the antiretroviral activity of eosinophils has been associated with the ribonuclease activity of EDN (26 ) . It was somewhat surprising to get RNase as a purification product because we took care to exclude the ribonucleases as candidates for reverse transcription inhibitors by testing various ribonuclease inhibitors in leukocyte lysate (Table 1) . It had been shown previously that one of the RNase inhibitors tested, Inhibit-ACE, is ineffective against EDN ribonuclease activity (25 ) . The use of heat as a means of inhibiting RNase activity (27, 28 ) requires that the sample be heated for at least 5 min to inactivate ribonucleases, during which period mRNA is degraded. Our experiments demonstrate that the usual inhibitors are ineffective against high concentrations of RNases in applications such as RT-PCR for the detection of minimal residual disease in leukemia.
Because EDN is expressed almost exclusively in eosinophils [small amounts have also been found in monocytes (20 ) and neutrophils (29 )], we selected eosinophil-free granulocytes with an antibody against the CD16 cell surface marker or mononuclear cells by Ficoll-Paque density gradient and tested the residual RT-inhibiting activity of these leukocyte fractions (Table 3) . Selection of eosinophil-free granulocytes with antibodies against CD16 reduced the EDN content of the cells to a concentration where 77% of the RNase-free signal could be recovered. Accordingly, a 53% signal was obtained from the mononuclear cell lysates, whereas only 24% of the signal was obtained when total RNA was extracted from leukocytes that had not been fractionated. The eosinophil- (30 ) that to avoid the action of ribonucleases, the extraction of RNA from eosinophil-infiltrated lung requires a modification to the acid guanidinium thiocyanate-phenol-chloroform extraction method of Chomczynski and Sacchi (12 ) . This supports the results of this study that eosinophil granulocytes are the main source of the ribonuclease activity in leukocytes. The removal of eosinophils from the leukocyte population substantially reduces the risk of mRNA destruction by eosinophil-derived ribonuclease. 
